2025 Russell Ross Memorial Lectureship in Vascular Biologyr – Kathryn J. Moore, PhD, FAHA


Saskia Middeldorp, MD, PhD
Saskia Middeldorp, MD, PhD

Kathryn J. Moore, PhD, FAHA

NYU Langone Health
New York, New York

 

Dr. Kathryn Moore is the Jean and David Blechman Professor of Cardiology and Director of the Cardiovascular Research Center at New York University’s Grossman School of Medicine. She is internationally recognized for her research on the molecular pathogenesis of cardiometabolic diseases, particularly the roles that non-coding RNAs and dysregulated immune responses play in those disorders. By forging new links between lipids, metabolism and innate immunity, her discoveries have revealed fundamental insights into pathways that regulate cholesterol homeostasis and vascular inflammation.

Dr. Moore received her PhD from McGill University in Canada. Although her early research focused on the immune response to pathogens, she became fascinated with the mechanisms of chronic inflammation and pursued postdoctoral training at Harvard Medical School in autoimmune and cardiovascular diseases. She joined the faculty at Harvard Medical School / Massachusetts General Hospital as an Assistant Professor, before moving to New York University School of Medicine, where she is a tenured professor in the departments of Medicine and Cell Biology.

Dr. Moore is an active volunteer for the American Heart Association and served on the Leadership Committee of the Arteriosclerosis, Thrombosis and Vascular Biology Council from 2004-18, including as Chair of the Council (2014-16). During her tenure, she helped to develop recommendations for AHA policies in science and medicine and made mentoring the next generation of scientists a top priority.

Dr. Moore’s contributions to the field of vascular biology have been recognized by numerous awards and honors, including the NIH’s Outstanding Investigator Award, Clarion’s List of Most Highly Cited Researchers, ATVB Mentor of Women Award, American Heart Association’s Distinguished Scientist Award, Gill Heart & Vascular Institute Award for Outstanding Contributions to Cardiovascular Research, Grand Prix Scientifique of the Lefoulon-Delalande Foundation and election to the National Academy of Sciences, among others.

 

Four Days. Global Experts. Limitless Discovery.

Scientific Sessions 2025
November 7–10, 2025
New Orleans, Louisiana

#AHA25 is the global stage for breakthrough cardiovascular science, uniting experts, innovators, and future leader for four immersive days of discovery and collaboration.